Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen Macarena, Department of Medicine, University of Seville, Institute of Biomedicine of Seville (IbiS), Seville, Spain.
Clinical Unit of Pharmacy, University Hospital Virgen del Rocio, Seville, Spain.
Clin Microbiol Infect. 2020 Mar;26(3):358-365. doi: 10.1016/j.cmi.2019.07.009. Epub 2019 Jul 16.
Inappropriate antimicrobial use favours the spread of resistance, and multidrug-resistant microorganisms (MDR) are currently of major concern. Antimicrobial stewardship programmes (ASPs) are essential for improving antibiotic use in hospitals. However, their impact on entire healthcare systems has not been thoroughly assessed. Our objective was to provide the results of an institutionally supported ASP involving 31 public hospitals in Andalusia, Spain.
We designed an ecologic time-series study from 1 January 2014 to 31 December 2017. Quarterly, data on indicators were collected prospectively, and feedback reports were provided. PIRASOA is an ongoing clinically based quality-improvement programme whose key intervention is the educational interview, regular peer-to-peer interventions between advisors and prescribers to reinforce the appropriate use of antibiotics. Seventy-two indicators were monitored to measure prescribing quality (inappropriate treatments), antimicrobial consumption (defined daily doses per 1000 occupied bed-days), incidence density of MDR per 1000 occupied bed-days and crude mortality rate associated with bloodstream infections. We used Joinpoint regression software to analyse the trends.
The quality of antimicrobial prescribing improved markedly, and the inappropriate treatment rate was significantly lower, with quarterly percentage change (QPC) = -3.0%, p < 0.001. Total antimicrobial consumption decreased (QPC = -0.9%, p < 0.001), specifically carbapenems, amoxicillin/clavulanic acid, quinolones and antifungal agents, whereas antipseudomonal cephalosporin use increased. While the incidence of MDR showed a sustained decreasing trend (QPC = -1.8%; p 0.002), the mortality of patients with bloodstream infections remained stable (QPC = -0.2%, p 0.605).
To date, the PIRASOA programme has succeeded in optimizing the use of antimicrobial agents and has had a positive ecologic result on bacterial resistance at level of an entire healthcare system.
不适当的抗菌药物使用有利于耐药性的传播,目前多药耐药微生物(MDR)是主要关注点。抗菌药物管理计划(ASP)对于改善医院的抗生素使用至关重要。然而,它们对整个医疗保健系统的影响尚未得到彻底评估。我们的目的是提供在西班牙安达卢西亚的 31 家公立医院参与的机构支持的 ASP 的结果。
我们设计了一项从 2014 年 1 月 1 日至 2017 年 12 月 31 日的生态学时间序列研究。每季度前瞻性收集指标数据,并提供反馈报告。PIRASOA 是一个正在进行的基于临床的质量改进计划,其主要干预措施是教育性访谈,顾问与处方者之间定期进行同行干预,以加强抗生素的合理使用。监测了 72 个指标,以衡量处方质量(不适当的治疗)、抗菌药物消耗(每 1000 个占用病床日的定义日剂量)、每 1000 个占用病床日的 MDR 发生率密度和与血流感染相关的粗死亡率。我们使用 Joinpoint 回归软件分析趋势。
抗菌药物处方的质量显著提高,不适当的治疗率显著降低,每季度百分比变化(QPC)=-3.0%,p<0.001。总抗菌药物消耗减少(QPC=-0.9%,p<0.001),特别是碳青霉烯类、阿莫西林/克拉维酸、喹诺酮类和抗真菌药物,而抗假单胞菌头孢菌素的使用增加。虽然 MDR 的发生率呈持续下降趋势(QPC=-1.8%;p<0.002),但血流感染患者的死亡率保持稳定(QPC=-0.2%,p=0.605)。
迄今为止,PIRASOA 计划成功优化了抗菌药物的使用,并对整个医疗保健系统的细菌耐药性产生了积极的生态结果。